These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9678442)

  • 41. Pretransplant alpha-interferon therapy in hemodialysis patients with hepatitis C virus related chronic liver disease.
    Oymak O; Akpolat T; Erdem Y; Yasavul U; Simşek H; Turgan C; Cağlar S
    Nephron; 1995; 69(3):340. PubMed ID: 7753273
    [No Abstract]   [Full Text] [Related]  

  • 42. Efficacy of interferon-alpha in the treatment of chronic hepatitis C in dialysis patients: two therapeutic protocols compared.
    Grgurević I; Vince A; Buljevac M; Banić M; Jeren-Strujić B; Kes P; Kujundzić M; Leko N; Lukić IK; Slavicek J
    Nephron Clin Pract; 2006; 103(1):c8-11. PubMed ID: 16374034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment in chronic renal failure].
    Curciarello J; Fernández JL; Silva M
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S55-7. PubMed ID: 20214305
    [No Abstract]   [Full Text] [Related]  

  • 44. [Current knowledge in the treatment of chronic hepatitis C].
    Pirotte J
    Rev Med Liege; 1995 Dec; 50(12):501-4. PubMed ID: 8570988
    [No Abstract]   [Full Text] [Related]  

  • 45. [Chronic viral hepatitis and kidney failure].
    Chaabane NB; Loghmari H; Melki W; Hellara O; Safer L; Bdioui F; Saffar H
    Presse Med; 2008 Apr; 37(4 Pt 2):665-78. PubMed ID: 18291615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon and steroid treatment in patients with chronic hepatitis C and antinuclear or anti-liver-kidney microsomal antibodies.
    Provenzano G; Almasio P; Fabiano C; Magrin S; Pinzello G; Vaccaro A; Craxì A
    Ital J Gastroenterol; 1996 Sep; 28(7):377-80. PubMed ID: 8937938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pegylated interferon for treatment in hemodialysis patients with chronic hepatitis C.
    Koksal I
    J Gastroenterol Hepatol; 2006 Mar; 21(3):491-4. PubMed ID: 16638088
    [No Abstract]   [Full Text] [Related]  

  • 48. [Complete cytogenetic response to interferon-alpha in a patient with chronic myelogenous leukemia undergoing hemodialysis].
    Doi S; Edamura S; Akasaka H; Kawamura M; Arima N; Nasu K
    Rinsho Ketsueki; 2001 Jul; 42(7):549-53. PubMed ID: 11524845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis.
    Rocha CM; Perez RM; Ferreira AP; Carvalho-Filho RJ; Pace FH; Silva IS; Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
    Liver Int; 2006 Apr; 26(3):305-10. PubMed ID: 16584392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C virus in hemodialysis patients.
    Espinosa M; Martín-Malo A; Aljama P
    Kidney Int; 2000 Jul; 58(1):462-3. PubMed ID: 10886596
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of daily administration period of natural alpha-interferon in patients with chronic hepatitis C.
    Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S
    Am J Gastroenterol; 1996 Apr; 91(4):743-7. PubMed ID: 8677941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy.
    Eurich D; Bahra M; Berg T; Boas-Knoop S; Biermer M; Neuhaus R; Neuhaus P; Neumann U
    Exp Clin Transplant; 2011 Feb; 9(1):1-6. PubMed ID: 21605016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of acute hepatitis C].
    Yokosuka O; Mikata R
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):357-60. PubMed ID: 15359821
    [No Abstract]   [Full Text] [Related]  

  • 54. Containing hepatitis C.
    Maddrey WC
    Hosp Pract (1995); 1997 Mar; 32(3):107-9, 113-4 passim; discussion 128. PubMed ID: 9078976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hepatitis C infections in dialyzed patients].
    Podlasin RB
    Przegl Epidemiol; 2005; 59(2):541-7. PubMed ID: 16190565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Three times weekly versus daily dose alpha-interferon treatment in patients with acute hepatitis C.
    Fabris P; Tositti G; Giordani MT; Infantolino D; de LF
    Am J Gastroenterol; 2002 Feb; 97(2):492-3. PubMed ID: 11866300
    [No Abstract]   [Full Text] [Related]  

  • 57. Acute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: case study.
    Fabrizi F; D'Ambrosio R; Pallotti F; Berardinelli L; Messa P; Martin P; Aghemo A
    Int J Artif Organs; 2014 Nov; 37(11):803-8. PubMed ID: 25362901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of anti-HCV seropositivity on the TNF-alpha level in hemodialysis patients.
    Sengil AZ; Gürbilek M; Altindiş M; Uysal H; Koşar A; Baysal B
    Clin Nephrol; 1995 Jul; 44(1):69-70. PubMed ID: 7554537
    [No Abstract]   [Full Text] [Related]  

  • 59. Complete response to interferon-alpha for acute hepatitis C after needlestick injury in a hemodialysis nurse.
    Poignet JL; Degos F; Bouchardeau F; Chauveau P; Courouce AM
    J Hepatol; 1995 Dec; 23(6):740-1. PubMed ID: 8750175
    [No Abstract]   [Full Text] [Related]  

  • 60. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.